{"title":"系统评价:超声通过肠道超声治疗炎症性肠病","authors":"Sara Massironi, Alessandra Zilli, Federica Furfaro, Mariangela Allocca, Laurent Peyrin‐Biroulet, Vipul Jairath, Silvio Danese","doi":"10.1111/apt.70385","DOIUrl":null,"url":null,"abstract":"BackgroundInflammatory bowel disease (IBD) is a chronic, resource‐intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD—gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)—are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.AimTo systematically assess the carbon footprint and environmental impact of diagnostic imaging modalities commonly used in IBD, with particular focus on intestinal ultrasound (IUS) as a sustainable, low‐carbon alternative.MethodsA systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Scopus and Embase were searched from inception to May 2025 for studies reporting the environmental impact of diagnostic modalities relevant to IBD care (GI endoscopy, CT, MRI and IUS). Studies providing quantitative or qualitative data on carbon footprint, energy consumption, waste generation or sustainability metrics were included. Data were synthesised narratively.ResultsThirty‐one studies were included. GI endoscopy generates approximately 7.8–56.4 kg CO<jats:sub>2</jats:sub>‐equivalent per procedure, largely driven by transportation, energy use and disposables. CT carries a carbon footprint of 7–10 kg CO<jats:sub>2</jats:sub>e per procedure in direct life cycle assessments, while broader institutional and modelling estimates extend this to ~20 kg CO<jats:sub>2</jats:sub>e depending on throughput, protocol and energy sources. MRI is substantially more energy‐intensive, ranging from 17–22 kg CO<jats:sub>2</jats:sub>e per scan in most studies, and up to 200–300 kg CO<jats:sub>2</jats:sub>e for high‐field (3T) systems when full life cycle impacts are included. In contrast, IUS produces only 0.5–1.5 kg CO<jats:sub>2</jats:sub>e per scan, with minimal energy demand and negligible waste. IUS enables point‐of‐care assessments, reducing patient travel and associated emissions.ConclusionGI endoscopy, CT and MRI are indispensable in IBD care but carry considerable environmental costs. The broader adoption of IUS offers a clinically effective, low‐carbon alternative that can contribute to more sustainable IBD management, aligning with planetary health goals.Trial RegistrationPROSPERO International Prospective Register of Systematic Reviews: CRD420251088016","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"53 1","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound\",\"authors\":\"Sara Massironi, Alessandra Zilli, Federica Furfaro, Mariangela Allocca, Laurent Peyrin‐Biroulet, Vipul Jairath, Silvio Danese\",\"doi\":\"10.1111/apt.70385\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BackgroundInflammatory bowel disease (IBD) is a chronic, resource‐intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD—gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)—are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.AimTo systematically assess the carbon footprint and environmental impact of diagnostic imaging modalities commonly used in IBD, with particular focus on intestinal ultrasound (IUS) as a sustainable, low‐carbon alternative.MethodsA systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Scopus and Embase were searched from inception to May 2025 for studies reporting the environmental impact of diagnostic modalities relevant to IBD care (GI endoscopy, CT, MRI and IUS). Studies providing quantitative or qualitative data on carbon footprint, energy consumption, waste generation or sustainability metrics were included. Data were synthesised narratively.ResultsThirty‐one studies were included. GI endoscopy generates approximately 7.8–56.4 kg CO<jats:sub>2</jats:sub>‐equivalent per procedure, largely driven by transportation, energy use and disposables. CT carries a carbon footprint of 7–10 kg CO<jats:sub>2</jats:sub>e per procedure in direct life cycle assessments, while broader institutional and modelling estimates extend this to ~20 kg CO<jats:sub>2</jats:sub>e depending on throughput, protocol and energy sources. MRI is substantially more energy‐intensive, ranging from 17–22 kg CO<jats:sub>2</jats:sub>e per scan in most studies, and up to 200–300 kg CO<jats:sub>2</jats:sub>e for high‐field (3T) systems when full life cycle impacts are included. In contrast, IUS produces only 0.5–1.5 kg CO<jats:sub>2</jats:sub>e per scan, with minimal energy demand and negligible waste. IUS enables point‐of‐care assessments, reducing patient travel and associated emissions.ConclusionGI endoscopy, CT and MRI are indispensable in IBD care but carry considerable environmental costs. The broader adoption of IUS offers a clinically effective, low‐carbon alternative that can contribute to more sustainable IBD management, aligning with planetary health goals.Trial RegistrationPROSPERO International Prospective Register of Systematic Reviews: CRD420251088016\",\"PeriodicalId\":121,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics\",\"volume\":\"53 1\",\"pages\":\"\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/apt.70385\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apt.70385","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound
BackgroundInflammatory bowel disease (IBD) is a chronic, resource‐intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD—gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)—are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.AimTo systematically assess the carbon footprint and environmental impact of diagnostic imaging modalities commonly used in IBD, with particular focus on intestinal ultrasound (IUS) as a sustainable, low‐carbon alternative.MethodsA systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Scopus and Embase were searched from inception to May 2025 for studies reporting the environmental impact of diagnostic modalities relevant to IBD care (GI endoscopy, CT, MRI and IUS). Studies providing quantitative or qualitative data on carbon footprint, energy consumption, waste generation or sustainability metrics were included. Data were synthesised narratively.ResultsThirty‐one studies were included. GI endoscopy generates approximately 7.8–56.4 kg CO2‐equivalent per procedure, largely driven by transportation, energy use and disposables. CT carries a carbon footprint of 7–10 kg CO2e per procedure in direct life cycle assessments, while broader institutional and modelling estimates extend this to ~20 kg CO2e depending on throughput, protocol and energy sources. MRI is substantially more energy‐intensive, ranging from 17–22 kg CO2e per scan in most studies, and up to 200–300 kg CO2e for high‐field (3T) systems when full life cycle impacts are included. In contrast, IUS produces only 0.5–1.5 kg CO2e per scan, with minimal energy demand and negligible waste. IUS enables point‐of‐care assessments, reducing patient travel and associated emissions.ConclusionGI endoscopy, CT and MRI are indispensable in IBD care but carry considerable environmental costs. The broader adoption of IUS offers a clinically effective, low‐carbon alternative that can contribute to more sustainable IBD management, aligning with planetary health goals.Trial RegistrationPROSPERO International Prospective Register of Systematic Reviews: CRD420251088016
期刊介绍:
Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.